AUTHOR

Dana Saffel, PharmD, DPh, CGP
President, CEO
PharmaCare Strategies, Inc.
Alpharetta, GA 30004

REVIEWER

John A. Kriak, Pharm D
Assistant Professor of Pharmacology
St. Francis University, Physician Assistant Sciences
Clinical Pharmacist, Rite Aid Corporation

DISCLOSURE

The author and reviewer report no financial arrangement or affiliation with commercial corporations whose products may be mentioned in this program.

ACCREDITATION

Pharmacists
Power-Pak C.E.™ is accredited by the Accreditation Council
for Pharmacy Education as a provider of
continuing pharmacy education.
Program No.: 424-000-04-023-H04
Credits: 2.0 hours (.20 ceu)

TARGET AUDIENCE

This accredited program is targeted to Pharmacists, Pharmacist Technicians and those with an interest in the discussion of stress urinary incontinence. Estimated time to complete this monograph and post-test is 90 to 120 minutes.

GOAL

The goal of this lesson is to discuss stress urinary incontinence. Emphasis is given to describing the impact it may have on a patient’s quality of life and non pharmacologic and pharmacologic options that may be beneficial in managing stress urinary incontinence.

EDUCATIONAL OBJECTIVES

At the conclusion of this program, participants will be able to:

1. Differentiate the signs and symptoms of stress, urge, overflow, and mix urinary incontinence;
2. Describe the physiology of the urinary tract and the role of neurotransmitters in maintaining continence;
3. Identify changes in the anatomy of the urinary tract that may result in stress urinary incontinence;
4. Describe the impact that urinary incontinence has on quality of life;
5. Recommend non-pharmacological treatment options that may be beneficial in managing stress urinary incontinence;
6. Differentiate the various pharmacological treatments that have been used for managing stress urinary incontinence in terms of efficacy and adverse effects; and
7. Identify patients who may benefit from a specific
   pharmacologic treatment for stress urinary incontinence.

The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the Food and Drug Administration. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.